Comments
Ace investor Ashish Kacholia bought a significant stake in Vivimed Labs on Tuesday. According to NSE bulk deal data, Ashish Kacholia bought 13.7 lakh shares of Vivimed Labs at an average price of ₹90.50 a share. This represents 1.7 per cent stake in the pharma major. While Nylim Jacob Ballas India Fund sold 48.7 lakh shares of Vivimed Labs, RBA Finance & Investment was the other buyer of 22 lakh shares or 2.74 per cent stake in the company at ₹90.50 per share. Shares of Vivimed Labs jumped 9.5 per cent to ₹112.6 on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.